Characteristics and management of giant cell arteritis in France: a study based on national health insurance claims data

Alfred Mahr 1 Manon Belhassen 2 Marc Paccalin 3 Valérie Devauchelle-Pensec 4, 5 Maeva Nolin 2 Sophie Gandon 6 Isabelle Idier 7 Eric Hachulla 8
1 CMRR Paris Nord Ile-de-France, Lariboisiere Fernand Widal Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris, University of Paris Diderot, Paris
2 PELyon, Pharmacoepidemiologie, Lyon
3 POITIERS - Médecine Interne, Endocrinologie - POITIERS
4 CHU - BREST - Rhumato - CHRU Brest - Service de Rhumatologie
5 LBAI - Lymphocyte B et Auto-immunité
6 Roche SAS, 30, cours de l'Ile Seguin, 92650, Boulogne-Billancourt, France.
7 Chugai Pharma France, Paris La Défense
8 service de médecine interne et immunologie clinique [CHU Lille]
Document type :
Journal articles
Complete list of metadatas
https://hal.univ-brest.fr/hal-02173068
Contributor : Geneviève Michel <>
Submitted on : Thursday, July 4, 2019 - 11:20:45 AM
Last modification on : Friday, July 5, 2019 - 1:35:34 AM

Identifiers

Collections

UNIV-BREST | IMMUNO | IBSAM

Citation

Alfred Mahr, Manon Belhassen, Marc Paccalin, Valérie Devauchelle-Pensec, Maeva Nolin, et al.. Characteristics and management of giant cell arteritis in France: a study based on national health insurance claims data. Rheumatology, Oxford University Press (OUP), 2019, ⟨10.1093/rheumatology/kez251⟩. ⟨hal-02173068⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

35

Contact

CCSD